XML 40 R28.htm IDEA: XBRL DOCUMENT
v3.19.2

Related Party Agreements (Details) - USD ($) $ in Thousands |  | 1 Months Ended | 3 Months Ended | 6 Months Ended |
--- | --- | --- | --- | --- | ---
Apr. 19, 2019 | May 31, 2019 | Apr. 30, 2019 | Mar. 29, 2019 | Jul. 31, 2016 | Jun. 30, 2019 | Jun. 30, 2018 | Jun. 30, 2019 | Jun. 30, 2018 | Dec. 31, 2018
Common Stock, Shares, Issued |  |  |  |  |  | 39,454,316 |  | 39,454,316 |  | 26,610,183
Annual Fees Expenses On Founders Agreement |  |  |  |  |  |  |  | $ 400 |  |
Common Stock, Shares, Outstanding |  |  |  |  |  | 39,454,316 |  | 39,454,316 |  | 26,610,183
Proceeds From Horizon Notes |  |  |  |  |  |  |  | $ 15,000 | $ 0 |
General and Administrative Expense. |  |  |  |  |  | $ 3,189 | $ 1,683 | $ 5,533 | $ 3,793 |
Market Offering |  |  |  |  |  |  |  |  |  |
Common Stock, Shares, Issued |  |  |  |  |  | 3,500,000 |  | 3,500,000 |  | 0
Proceeds From Horizon Notes |  |  |  |  |  | $ 22,500 |  | $ 22,500 |  |
Public Offering [Member] |  |  |  |  |  |  |  |  |  |
Common Stock, Shares, Issued |  |  | 6,875,000 |  |  |  |  |  |  |
Proceeds From Horizon Notes |  |  | $ 31,600 |  |  |  |  |  |  |
City of Hope |  |  |  |  |  |  |  |  |  |
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners |  |  |  |  |  | 3.20% |  | 3.20% |  |
Fortress Biotech, Inc |  |  |  |  |  |  |  |  |  |
Stock Issued During Period, Shares, Issued for Services |  |  |  | 108,069 |  |  |  |  |  |
Fortress Biotech, Inc | Market Offering |  |  |  |  |  |  |  |  |  |
Stock Issued During Period, Shares, Issued for Services | 87,656 |  |  |  |  |  |  |  |  |
Proceeds From Horizon Notes | $ 22,500 |  |  |  |  |  |  |  |  |
Shares Of Common Stock, Percentage | 2.50% |  |  |  |  |  |  |  |  |
General and Administrative Expense. |  |  |  |  |  |  |  | $ 500 |  |
Fortress Biotech, Inc | Public Offering [Member] |  |  |  |  |  |  |  |  |  |
Common Stock, Shares, Issued |  | 197,656 |  |  |  |  |  |  |  |
Proceeds From Horizon Notes |  | $ 31,600 |  |  |  |  |  |  |  |
Shares Of Common Stock, Percentage |  | 2.50% |  |  |  |  |  |  |  |
General and Administrative Expense. |  |  |  |  |  |  |  | $ 800 |  |
Fortress Biotech, Inc | Research and Development Expense |  |  |  |  |  |  |  |  |  |
Annual Fees Expenses On Founders Agreement Percentage |  |  |  |  |  | 50.00% | 50.00% | 50.00% | 50.00% |
Fortress Biotech, Inc | General and Administrative Expense |  |  |  |  |  |  |  |  |  |
Annual Fees Expenses On Founders Agreement Percentage |  |  |  |  |  | 50.00% | 50.00% | 50.00% | 50.00% |
Class A Preferred Stock |  |  |  |  |  |  |  |  |  |
Stock Issued During Period, Shares, Issued for Services |  |  |  |  |  |  |  | 0 | 0 |
Conversion of Stock, Shares Converted |  |  |  |  |  | 0 |  | 0 |  |
Class A Preferred Stock | Fortress Biotech, Inc |  |  |  |  |  |  |  |  |  |
Preferred Stock, Dividend Rate, Percentage |  |  |  |  | 2.50% |  |  |  |  |
Common Stock A One | City of Hope |  |  |  |  |  |  |  |  |  |
Common Stock, Shares, Outstanding |  |  |  |  |  | 862,392 |  | 862,392 |  |
Common Stock A Two | City of Hope |  |  |  |  |  |  |  |  |  |
Common Stock, Shares, Outstanding |  |  |  |  |  | 431,196 |  | 431,196 |  |
Class A Common Shares |  |  |  |  |  |  |  |  |  |
Common Stock, Shares, Issued |  |  |  |  |  | 862,392 |  | 862,392 |  | 1,000,000
Common Stock, Shares, Outstanding |  |  |  |  |  | 862,392 |  | 862,392 |  | 1,000,000
Stock Issued During Period, Shares, Issued for Services |  |  |  |  |  |  |  | 0 | 0 |
Conversion of Stock, Shares Converted |  |  | 137,608 |  |  | (137,608) |  | (137,608) |  |
Common Shares |  |  |  |  |  |  |  |  |  |
Stock Issued During Period, Shares, Issued for Services |  |  |  |  |  |  |  | 709,314 | 834,756 |
Conversion of Stock, Shares Converted |  |  | 137,608 |  |  | 137,608 |  | 137,608 |  |
Common Shares | Fortress Biotech, Inc |  |  |  |  |  |  |  |  |  |
Shares Of Common Stock, Percentage |  |  |  | 2.50% |  |  |  |  |  |

X
- Definition This element represents the amount of expenses on the founders agreement for annual fees. + References No definition available. + Details
Name: | mbio_AnnualFeesExpensesOnFoundersAgreement
Namespace Prefix: | mbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of expenses recognized under respective heads of consolidated statement of operations. + References No definition available. + Details
Name: | mbio_AnnualFeesExpensesOnFoundersAgreementPercentage
Namespace Prefix: | mbio_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Proceeds from horizon notes. + References No definition available. + Details
Name: | mbio_ProceedsFromHorizonNotes
Namespace Prefix: | mbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition It represents of the percentage rate of common stock. + References No definition available. + Details
Name: | mbio_SharesOfCommonStockPercentage
Namespace Prefix: | mbio_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586 + Details
Name: | us-gaap_ConversionOfStockSharesConverted1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 + Details
Name: | us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage rate used to calculate dividend payments on preferred stock. + References No definition available. + Details
Name: | us-gaap_PreferredStockDividendRatePercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=mbio_MarketOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=mbio_PublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=mbio_CityOfHopeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mbio_FortressBiotechIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=mbio_CommonStockOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=mbio_CommonStockTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |